Fundraising Fox

Bolt Therapeutics

Pleasanton, US · Founded 2015 · Delaware corporation · 2 known investors

Founders & leadership

CL
Chih-Ping LiuNamed on SEC filing

Board

EGEdgar G Engleman
Edgar G EnglemanBoard directorManaging Partner at Vivo Capital

Investors · 2

Sofinnova VenturesMenlo Park · $100K – $15M
Vivo CapitalreportedPalo Alto · $10M – $50Mvia Edgar G. Engleman · board

Reported raises · per SEC filings

Form D private placements

$178.6M disclosed across 7 rounds · 2015–2021

▶$15MraisedJun 2021 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • William QuinnExecutive Officer
  • Mahendra ShahDirector
  • Ashish KhannaDirector
  • Richard MillerDirector
  • Edgar EnglemanDirector
  • Edith PerezExecutive Officer
  • David DornanExecutive Officer
  • Grant YonehiroExecutive Officer
  • James HealyDirector
  • Peter MoldtDirector
  • Kathleen LaPorteDirector
  • Randall SchatzmanExecutive Officer, Director
Offering amount
$15M
Amount sold
$15M
First sale
Jun 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$93.5MraisedJan 2021 · 17 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Edith PerezExecutive Officer
  • David DornanExecutive Officer
  • William QuinnExecutive Officer
  • Randall SchatzmanExecutive Officer, Director
  • Kathleen LaPorteDirector
  • Mahendra ShahDirector
  • James HealyDirector
  • Richard MillerDirector
  • Ashish KhannaDirector
  • Edgar EnglemanDirector
  • Grant YonehiroExecutive Officer
Offering amount
$93.5M
Amount sold
$93.5M
First sale
Jun 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$40.1MraisedJul 2019 · 11 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Grant YonehiroExecutive Officer
  • Ashish KhannaDirector
  • Richard MillerDirector
  • Mahendra ShahDirector
  • Edgar EnglemanExecutive Officer, Director
  • Peter MoldtDirector
Offering amount
$40.1M
Amount sold
$40.1M
First sale
Jul 2019
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$13.4MraisedAug 2018 · 11 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Ashish KhannaDirector
  • Grant YonehiroExecutive Officer
  • Edgar G. EnglemanDirector
  • Mahendra ShahDirector
  • Peter MoldtDirector
Offering amount
$13.4M
Amount sold
$13.4M
First sale
Jul 2018
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$6MraisedFeb 2018 · 6 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Edgar G. EnglemanExecutive Officer, Director
  • Grant YonehiroExecutive Officer
  • Peter MoldtDirector
  • Ken HarrisonDirector
  • Mahendra ShahDirector
Offering amount
$6M
Amount sold
$6M
First sale
Feb 2018
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$10MraisedSep 2016 · 6 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Edgar G. EnglemanExecutive Officer, Director
  • Reiner LausExecutive Officer, Director
  • Peter BisgaardDirector
  • Peter MoldtDirector
  • Mahendra ShahDirector
Offering amount
$16M
Amount sold
$10M
First sale
Sep 2016
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$600KraisedMay 2015 · 2 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Chih-Ping LiuExecutive Officer, Director, Promoter
  • Edgar G EnglemanDirector
Offering amount
$800K
Amount sold
$600K
First sale
May 2015
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Pfizer-backed Bolt Therapeutics strikes $93.5M funding round as lead med hits the clinic | Fierce Biotechfiercebiotech.com · Jul 2020

Frequently asked questions

Who are Bolt Therapeutics's investors?
Bolt Therapeutics's investors include Sofinnova Ventures, Vivo Capital.
How much funding has Bolt Therapeutics raised?
Bolt Therapeutics has disclosed $178.6M raised across 7 rounds.
Where is Bolt Therapeutics headquartered?
Bolt Therapeutics is headquartered in Pleasanton, US.